Skip to content

Follow up of Patients Treated With Cognitive Behavioural Therapy for Hypochondria From 1997 to 2007

Follow up of Patients Treated With Cognitive Behavioural Therapy at Clinic for Hypochondriacs, Haraldsplass Deaconal Hospital, From 1997 to 2007

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00959452
Enrollment
250
Registered
2009-08-14
Start date
1997-01-31
Completion date
2022-12-31
Last updated
2023-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypochondriasis

Keywords

Hypochondria, Cognitive behavioural therapy, Long term follow-up, Psychosomatics, Psychotherapy

Brief summary

Research has shown that cognitive behavioural therapy is effective in treating hypochondria. However, no studies have examined the long term effect. The investigators have followed 56 patients treated for hypochondria between 1997 and 2001 and the investigators are now doing a 10 year follow-up (Part I). In another part of the study (Part II) the investigators compare the effect of 16 sessions vs. 5 sessions, with a follow-up period of at least 2 years. The investigators hypothesis is that the initial 1 year improvement will be sustained and that 5 sessions will yield the same results as 16 sessions.

Detailed description

The follow-up includes a telephone interview by independent researcher and the patients fill in the following questionnaires: Whiteley Index (measures health anxiety), VAS-scales for health anxiety, worrying about symptoms and body checking, SF-36 (health related quality of life), Giessen Subjective Complaints List, Spielberger Trait and State Anxiety Scale Beck Depression Inventory, Eysenck Personality Questionnaire, General Health Questionnaire (GHQ 28), Somatic Amplification Scale,

Interventions

BEHAVIORALCognitive behavioural therapy

16 sessions vs 5 sessions of cognitive behavioural therapy

Sponsors

University of Bergen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Fulfilling ICD-10 criteria for hypochondriacal disorder

Exclusion criteria

* Unwillingness to participate * Substance abuse * Serious psychological (f.inst. psychosis, major depression) or somatic (f.inst. cancer) disease

Design outcomes

Primary

MeasureTime frame
Level of health anxiety10 years follow up

Secondary

MeasureTime frame
Health related quality of life10 years follow-up

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026